Home/Filings/4/0001193125-25-296985
4//SEC Filing

Baker Daniel G. 4

Accession 0001193125-25-296985

CIK 0001645460other

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 4:00 PM ET

Size

5.3 KB

Accession

0001193125-25-296985

Insider Transaction Report

Form 4
Period: 2025-09-29
Baker Daniel G.
CHIEF DEVELOPMENT OFFICER
Transactions
  • Award

    Stock Option (right to buy)

    2025-09-29+50,00050,000 total
    Exercise: $0.72Exp: 2035-09-28Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]This stock option becomes fully exercisable on the first anniversary of the grant date.

Documents

1 file

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1
  • filerCIK 0002046802

Filing Metadata

Form type
4
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 4:00 PM ET
Size
5.3 KB